Quinolone levels in serum and maxillofacial tissues under ibuprofen co-administration following surgical trauma

Journal of Musculoskeletal Neuronal Interactions

Volumn 3, Issue 2, 2003, Pages 170-175

  Trichilis, A ^a   Saranteas, Th ^a   Potamianou, A ^a   Mourouzis, C ^b   Tesseromatis, Christina ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b KAT HOSPITAL   (Greece)

Author keywords

Free fatty acids; Ibuprofen; Quinolones; Serum; Trauma

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; CEPHALOSPORIN; CINOXACIN; CIPROCIN; CIPROFLOXACIN; FATTY ACID; IBUPROFEN; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; NORFLOXACIN; NOROCIN; OFLOXACIN; PEFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADRENAL GLAND; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACILLUS SUBTILIS; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG PENETRATION; DRUG TISSUE LEVEL; MANDIBLE; MAXILLOFACIAL SURGERY; MOUTH CAVITY; NONHUMAN; ORGAN WEIGHT; PAROTID GLAND; POSTOPERATIVE INFECTION; POSTOPERATIVE PAIN; PRESCRIPTION; RAT; RAT STRAIN; SURGICAL STRESS; SURGICAL TECHNIQUE; TONGUE;

EID: 0041670859     PISSN: 11087161     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Eichelstroem J. Drug pharmacokinetics in the postoperative period. Clin Pharmacokinet 1979; 4:16-20.
2. Birke G, Carlsson, LA, Liljedahl SO. Lipid metabolism and trauma. III. Plasma lipids and lipoproteins in burns. Acta Med Scand 1965; 178:337-350.
3. Tesseromatis C, Tsopanakis C, Symeonoglou G, Loukissa M, Varonos D. How harmless is FFA enhancement? Eur J Drug Metab Pharmacokinet 1996; 21:213-215.
4. Thoren L. Metabolic response to injury. Surg Annu 1975; 7:53-70.
5. Johnston IDA, Welbourn RB. Metabolic and endocrine response to trauma. Surg Annu 1970; 8:91-101.
6. Bergan T. Pharmacokinetics of fluorinated quinolones. In: Andriole VT (ed) The quinolones. Bayer, Academic Press; 1988:119-154.
7. Bergan T. Pharmacokinetic properties of the cephalosporins. Drugs 1987; 34(Suppl.2):89-104.
8. Patton JH, Reeves DS. Fluoroquinolone antibiotics. Microbiology, pharmacokinetics and clinical use. Drugs 1988; 36:193-228.
9. Hart FD, Huskisson EC. Non-steroidal antiiflammatory drugs. Current status and rational therapeutic use. Drugs 1984; 27:232-255.
10. Monti NC, Gazzaniga A, Giansello V. Activity and pharmacokinetics of a new oral dosage form of soluble ibuprofen. Arzneim-Forsch Drug Res 1992; 42:556-559.
11. Bennet VJ, Brodie LJ, Benner LE, Kirby NW. Simplified accurate method to antibiotic of clinical specimens. Appl Microbiol 1966; 14:170-177.
12. Furner RL, Stitzel RE. Stress-induced alterations in microsomal drug metabolism in the adrenalectomised animal. Biochem Pharmacol 1968; 10:121-127.
13. Kant GJ, Bunnell BN, Mougey EH, Pennington LL, Meyerhoff JL. Effects of repeated stress on pituitary cyclic AMP, and plasma prolactin, corticosterone and growth hormone in male rats. Pharmacol Biochem Behav 1983; 18:967-971.
14. Pollack GM, Browne JL, Marton J, Haberer LJ. Chronic stress impairs oxidative and hepatic excretion of model xenobiotic substrates in the rat. Drug Metab Dispos 1991; 19:130-134.
15. Fremstad D, Bergerud K, Haffner JFW, Lunde PK. Increased protein binding of quinidine after surgery: a preliminary report. Eur J Clin Pharmacol 1976; 10:441-446.
16. Soltys BJ, Hsia JC. Steroid modulation of human serum albumin binding properties. A spin label study. J Biol Chem 1978; 253:4266-4269.
17. Caffruny EL. Renal tubular handling of drugs. Am J Med 1977; 62:491-502.
18. Wingender W, Grade K, Graafe KH, Gau W, Forster D, Beerman D, Scacht P. Pharmacokinetics of ciprofloxacin after oral administration and IV administration. Eur J Clin Microbiol 1984; 3:355-359.
19. Trichilis A, Tesserommatis C, Varonos D. Changes in serum levels of quinolones in rats under the influence of experimental trauma. Eur J Drug Metab Pharmacokinet 2000; 25:73-78.
20. Tesseromatis C, Trichilis A, Tivos E, Messari J, Trianhaphylidis H, Varonos DD. Does stress influence ampicillin concentration in serum and tissues? Eur J Drug Metab Pharmacokinet 2001; 26:69-72.
21. Ozturk F, Kortunay S, Kurt E, Ilker SS, Inan UU, Basci NE, Bozkurt A, Kayaalp O. Effects of trauma and infection on ciprofloxacin levels in the vitrous cavity. Retina 1999; 19:127-130.
22. Griffeth LK, Rosen GM, Tschanz C, Rauckman EJ. Effects of model traumatic injury on hepatic drug metabolism in the rat. I. In vivo antipyrine metabolism. Drug Metab Disp 1983; 11:517-525.
23. Griffeth LK, Rosen GM, Rauckman EJ. Effects of model traumatic injury on hepatic drug metabolism in the rat. V. Sulfation and acetylation. Drug Metab Disp 1985; 13:398-405.
24. Griffeth LK, Rosen GM, Rauckman EJ. Effects of model traumatic injury on hepatic drug metabolism in the rat. VI. Major detoxification/toxification pathways. Drug Metab Disp 1987; 15:749-759.
25. Rauckman EJ, Rosen GM, Post SE, Gillogly SD. Effect of model traumatic injury on hepatic drug-metabolising enzymes. J Trauma 1980; 20:884-886.
26. Taeschner W, Vozeh S. Pharmacokinetic drug data. In: Speight TM, Holford NHG (eds) Avery's drug treatment. Adis International; 1997:1647.
27. Sorgel F. Penetration of temofloxacin into body tissues and fluids. Clin Pharmacokinet 1992; 22(Suppl.1):57-63.
28. Mizuno J, Sugimoto S, Kaneko A, Tsutsui T, Zushi N, Machida K. Convulsion following the combination of single preoperative oral administration of enoxacine and single postoperative intravenous administration of flurbiprofen axetil. Masui 1999; 50:425-428.
29. Squires RF, Saederup E. Indomethacin/ibuprofen-like anti-inflammatory agents selectively potentiate the gamma-aminobutyric acid-antagonistic effects of several norfloxacin-like quinolone antibacterial agents on [35S]t-butylbicyclophosphorothionate binding. Mol Pharmacol 1993; 795-800.
30. Yakushiji T, Shirasaki T, Akaide N. Non-competitive inhibition of GABA-A responses by a new class of quinolones and non-steroid anti-inflammatory in dissociated frog sensory neurones. Br J Pharmacol 1992; 105:13-18.
31. Palmer R, Haig A, Flavin S, Iyengar M. Effects of ibuprofen, nabumetone and celecoxib on blood pressure control in hypertensive patients on ACE inhibitors. Am J Hypert 2001; 14(Suppl.1):A85.
32. Matsuo Y, Yano I, Habu Y, Katsura T, Hashimoto Y, Inui K. Transport of levofloxacin in the OK kidney epithelial cell line: interaction with p-aminohippurate transport. Pharm Res 2001; 18:57.
33. Giabattoni G, Cinotti GA, Pierucci A, Semonetti BM, Mauzi M, Pugliese F. Effects of sulindac and ibuprofen in patients with chronic glomerular disease. Evidence for the dependence of renal function on prostacyclin. N Engl J Med 1984; 310:279-283.
34. Deplaces N, Acar JF. New quinolones in the treatment of joint and bone infections. Rev Infect Dis 1988; 10(Suppl.1):S179-183.